US2002136663A1PendingUtilityA1

Method for simplified shipping of clinical specimens and optional direct analysis

47
Assignee: BIOAVAILABILITY SYSTEMS LLCPriority: Sep 8, 2000Filed: May 21, 2002Published: Sep 26, 2002
Est. expirySep 8, 2020(expired)· nominal 20-yr term from priority
Inventors:James W. Harris
G01N 1/28G01N 2001/005G01N 2001/305
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for shipping clinical specimens lawfully, safely, cheaply, and easily without regard to some or all of the laws, rules, and regulations regarding samples that may contain infectious and/or etiologic agents. Optional method of direct analysis of shipped samples.

Claims

exact text as granted — not AI-modified
1 . A method of shipping, comprising converting a clinical specimen into a safe clinical sample, and shipping said safe clinical sample.  
     
     
         2 . The method of  claim 1 , wherein said safe clinical sample is shipped to a testing laboratory.  
     
     
         3 . The method of  claim 1 , wherein said safe clinical sample is lawfully packaged and labeled for shipping in a manner that does not comply with at least one State or Federal law, rule, or regulation regarding the shipping of a clinical specimen.  
     
     
         4 . The method of  claim 2 , wherein said safe clinical sample is lawfully packaged and labeled for shipping in a manner that does not comply with at least one State or Federal law, rule, or regulation regarding the shipping of a clinical specimen.  
     
     
         5 . The method of  claim 1 , wherein said safe clinical sample is shipped without any provision for sample temperature control or maintenance.  
     
     
         6 . The method of  claim 2 , wherein said safe clinical sample is shipped without any provision for sample temperature control or maintenance.  
     
     
         7 . The method of  claim 4 , wherein said safe clinical sample is shipped without any provision for sample temperature control or maintenance.  
     
     
         8 . The method of  claim 2 , wherein said safe clinical sample is received by said laboratory and directly subjected to laboratory analysis without substantial sample preparation.  
     
     
         9 . The method of  claim 4 , wherein said safe clinical sample is received by said laboratory and directly subjected to laboratory analysis without substantial sample preparation.  
     
     
         10 . The method of  claim 6 , wherein said safe clinical sample is received by said laboratory and directly subjected to laboratory analysis without substantial sample preparation.  
     
     
         11 . The method of  claim 8 , wherein the laboratory analysis determines the amount or concentration of a drug in the sample.  
     
     
         12 . The method of  claim 9 , wherein the laboratory analysis determines the amount or concentration of a drug in the sample.  
     
     
         13 . The method of  claim 10 , wherein the laboratory analysis determines the amount or concentration of a drug in the sample.  
     
     
         14 . The method of  claim 8 , wherein the laboratory analysis determines the amount or concentration of a chemical in the sample.  
     
     
         15 . The method of  claim 9 , wherein the laboratory analysis determines the amount or concentration of a chemical in the sample.  
     
     
         16 . The method of  claim 10 , wherein the laboratory analysis determines the amount or concentration of a chemical in the sample.  
     
     
         17 . The method of  claim 1 , wherein said water-miscible organic solvent is ethanol or denatured alcohol.  
     
     
         18 . The method of  claim 2 , wherein said water-miscible organic solvent is ethanol or denatured alcohol.  
     
     
         19 . The method of  claim 4 , wherein said water-miscible organic solvent is ethanol or denatured alcohol.  
     
     
         20 . The method of  claim 5 , wherein said water-miscible organic solvent is ethanol or denatured alcohol.  
     
     
         21 . The method of  claim 8 , wherein said water-miscible organic solvent is ethanol or denatured alcohol.  
     
     
         22 . The method of  claim 14 , wherein said water-miscible organic solvent is ethanol or denatured alcohol.  
     
     
         23 . The method of  claim 1 , wherein said clinical specimen does contain an etiologic agent.  
     
     
         24 . The method of  claim 2 , wherein said clinical specimen does contain an etiologic agent.  
     
     
         25 . The method of  claim 4 , wherein said clinical specimen does contain an etiologic agent.  
     
     
         26 . The method of  claim 5 , wherein said clinical specimen does contain an etiologic agent.  
     
     
         27 . The method of  claim 8 , wherein said clinical specimen does contain an etiologic agent.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.